Skip to content

Mounjaro Weight Loss Injection

Mounjaro is a once-weekly prescription injection containing tirzepatide, used to support weight management in eligible adults. It works by influencing appetite and blood sugar regulation, helping to reduce hunger, manage cravings and support better portion control alongside healthy lifestyle changes.

Price range: £149.99 through £899.97

Clear

Your Health & Wellness Centre

Trusted pharmacy advice, tips and guides for all your healthcare needs

UK Pharmacist Prescribers

Safe & compliant prescribing

GPhC-Approved

UK-Registered Pharmacy

No GP Appointments Needed

Quick, hassle-free online consultation

Secure & Confidential

Your data is 100% protected

Fast & Discreet Delivery

Next-day UK delivery available

NHS Services

NHS Providing Service since 2020

Additional information

Strength

STARTING DOSE 2.5MG, STEP UP DOSE 5MG, STEP UP DOSE 7.5MG, STEP UP DOSE 10MG, STEP UP DOSE 12.5MG, HIGHEST DOSE 15MG

Quantity

1 PEN (4 DOSES), 2 PENS (8 DOSES), 3 PENS (12 DOSES)

Description

Treatment Information, Doses and Pricing

Mounjaro is a prescription-only medicine containing tirzepatide. It is administered once a week and is licensed in the UK for weight management in eligible adults when used alongside a reduced-calorie diet and increased physical activity.

For further information about how tirzepatide is assessed and recommended for weight management within the NHS, you can read the NICE guidance on tirzepatide for managing overweight and obesity (TA1026). NICE guidance includes specific recommendations and eligibility criteria for NHS-funded treatment.

Before Mounjaro can be prescribed, an appropriate clinical assessment is required. The prescriber will consider your BMI, medical history, existing health conditions, current medicines and other relevant information before deciding whether treatment is suitable.

At Chesterfield Delivery Pharmacy, prescription weight-management treatment is only supplied following an appropriate consultation and clinical approval.

Please check our delivery information before ordering for the latest dispatch and delivery arrangements.

Mounjaro UK Price Information

The cost of Mounjaro varies according to the strength prescribed and the number of pens required.

Treatment normally starts at the lowest dose before being gradually increased, so your prescribed strength may change during treatment.

Mounjaro Dose 1 Pen (4 Doses) 2 Pens (8 Doses) 3 Pens (12 Doses)
2.5 mg £149.99 £299.98 £449.97
5 mg £184.99 £369.98 £554.97
7.5 mg £234.99 £469.98 £704.97
10 mg £259.99 £519.98 £779.97
12.5 mg £279.99 £559.98 £839.97
15 mg £299.99 £599.98 £899.97

 

Prices should be checked against the current Chesterfield Delivery Pharmacy price list before publication or ordering.

The dose prescribed should always be based on clinical suitability rather than price.

What is Mounjaro?

Mounjaro is a once-weekly injectable medicine containing the active ingredient tirzepatide.

For weight management, it is licensed for eligible adults with obesity or overweight who meet the appropriate clinical criteria. Tirzepatide is also licensed for the treatment of type 2 diabetes in appropriate patients.

Mounjaro works by acting on two naturally occurring hormone pathways called GIP and GLP-1. These hormones are involved in appetite regulation, digestion and blood glucose control.

For people receiving Mounjaro for weight management, treatment may help reduce hunger, increase feelings of fullness and make it easier to manage portion sizes.

Mounjaro should be used alongside appropriate dietary changes and regular physical activity rather than as a replacement for a healthy lifestyle.

What is Mounjaro used for?

For adult weight management, Mounjaro may be considered for people with:

  • A BMI of 30 kg/m² or above; or
  • A BMI of 27 kg/m² to below 30 kg/m² together with at least one weight-related health condition.

Relevant conditions can include:

  • High blood pressure
  • Abnormal cholesterol or blood lipid levels
  • Obstructive sleep apnoea
  • Cardiovascular disease
  • Prediabetes
  • Type 2 diabetes

Mounjaro is also licensed to help manage blood glucose in people with type 2 diabetes who meet the relevant clinical criteria.

Eligibility is not determined by BMI alone. Your prescriber will review your overall health and medical history before deciding whether tirzepatide is appropriate.

How does Mounjaro work?

Tirzepatide acts on both GIP and GLP-1 receptors.

These hormones play several roles within the body, including helping regulate appetite and blood glucose.

Mounjaro can:

  • Help reduce appetite
  • Increase feelings of fullness after eating
  • Support better portion control
  • Slow stomach emptying
  • Improve blood glucose regulation in people with type 2 diabetes
  • Support weight reduction when combined with appropriate lifestyle changes

The dual GIP and GLP-1 mechanism distinguishes tirzepatide from medicines that act only on the GLP-1 receptor.

Individual responses vary, and Mounjaro should always be used exactly as prescribed.

What is the Mounjaro dosing schedule?

Mounjaro treatment starts at a low dose and is increased gradually.

The usual starting dose is:

  • 2.5 mg once weekly for the first 4 weeks

The dose is then normally increased to:

  • 5 mg once weekly

If additional treatment benefit is required and the medicine is being tolerated, the dose can be increased in 2.5 mg steps after at least four weeks on the current dose.

Available strengths include:

  • 2.5 mg
  • 5 mg
  • 7.5 mg
  • 10 mg
  • 12.5 mg
  • 15 mg

The recommended adult maintenance doses are generally 5 mg, 10 mg or 15 mg once weekly, depending on individual response and clinical requirements.

The maximum dose is 15 mg once weekly.

Never increase your dose yourself. Your prescriber will advise when and whether your dose should change.

How much weight could I lose with Mounjaro?

The amount of weight lost while taking Mounjaro differs considerably between individuals.

In the SURMOUNT-1 clinical study involving adults with obesity or overweight without type 2 diabetes, participants receiving tirzepatide alongside dietary and physical activity support experienced significant average weight reduction over 72 weeks.

In one trial analysis, average body-weight reductions were approximately:

  • 16.0% with 5 mg
  • 21.4% with 10 mg
  • 22.5% with 15 mg

These figures are averages from a clinical trial and should not be interpreted as a guarantee of individual results.

Your response may depend on:

  • Your starting weight and BMI
  • The dose prescribed
  • How consistently treatment is followed
  • Dietary habits
  • Physical activity
  • Existing health conditions
  • Your individual response to tirzepatide

A weight-loss calculator can provide an illustration based on percentage weight reduction, but it cannot predict exactly how much weight you will lose.


 

Clinical Review and Pharmacy OversightThe treatment information provided on this website is reviewed under the clinical governance of Rayaz Ahmed, Superintendent Pharmacist at Chesterfield Delivery Pharmacy (GPhC: 2082789).

As a UK-registered pharmacist, Rayaz Ahmed oversees the professional and clinical standards followed by Chesterfield Delivery Pharmacy, including patient safety, medicines governance and the quality of healthcare information presented across our online pharmacy.

All prescription medicines supplied through Chesterfield Delivery Pharmacy are subject to an appropriate clinical assessment before treatment is approved. A qualified prescriber will review relevant information such as your medical history, current medicines, existing health conditions, allergies and overall suitability for the requested treatment before deciding whether a prescription can be issued.

This applies across our range of prescription treatments, including medicines for weight management, men’s health, women’s health, skin conditions, allergies, infections and other eligible health concerns.

Our treatment information is reviewed and updated where appropriate to help ensure it remains consistent with current UK prescribing information, regulatory standards and recognised clinical guidance.

Superintendent Pharmacist

Rayaz Ahmed
Superintendent Pharmacist
GPhC Registration Number: 2082789

Side Effects

Possible Side Effects of Mounjaro

Like all medicines, Mounjaro can cause side effects, although not everybody will experience them.

Digestive symptoms are among the most frequently reported side effects, particularly when treatment begins or when the dose is increased.

Common side effects can include:

  • Nausea
  • Diarrhoea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion
  • Bloating
  • Burping
  • Flatulence
  • Acid reflux
  • Reduced appetite
  • Feeling tired
  • Injection-site reactions

Some digestive side effects may improve as your body becomes accustomed to treatment.

More serious Mounjaro side effects

Some reactions require prompt medical attention.

Pancreatitis

Acute pancreatitis has been reported in people taking tirzepatide.

Seek immediate medical attention if you develop severe and persistent abdominal pain, particularly if the pain spreads towards your back. It may occur with or without vomiting.

Low blood sugar

The risk of hypoglycaemia may increase if Mounjaro is used alongside insulin or certain diabetes medicines known as sulphonylureas.

Possible symptoms include:

  • Sweating
  • Shaking
  • Dizziness
  • Hunger
  • Weakness
  • Rapid heartbeat
  • Confusion
  • Difficulty concentrating

Your diabetes medicines may need to be adjusted by your healthcare professional.

Serious allergic reactions

Rare but serious allergic reactions can occur.

Seek urgent medical assistance if you develop:

  • Swelling of the face, lips, tongue or throat
  • Difficulty breathing or swallowing
  • Severe dizziness
  • Symptoms of a severe allergic reaction

Dehydration and kidney problems

Vomiting and diarrhoea can result in dehydration.

Significant fluid loss may worsen kidney function, particularly in people who already have kidney problems.

Make sure you drink enough fluids and seek medical advice if vomiting or diarrhoea becomes severe or persistent.

Gallbladder problems

Gallstones and inflammation of the gallbladder can occur in some patients.

Seek medical advice if you develop severe upper abdominal pain, particularly if accompanied by fever, vomiting or yellowing of the skin or eyes.

When should I speak to my healthcare professional?

Contact your prescriber if side effects:

  • Become severe
  • Continue for an extended period
  • Prevent you from eating or drinking normally
  • Become worse after a dose increase
  • Cause symptoms that concern you

Always read the Patient Information Leaflet supplied with your medicine for the complete list of possible side effects.

Storage

How should Mounjaro be stored?

Mounjaro KwikPens should be stored correctly to maintain the quality of the medicine.

Before use:

  • Store Mounjaro in a refrigerator between 2°C and 8°C
  • Do not freeze
  • Do not use a pen that has been frozen
  • Protect the medicine appropriately from light
  • Keep it out of the sight and reach of children

After first use, a Mounjaro KwikPen may be kept outside the refrigerator for up to 30 days, provided the temperature does not exceed 30°C.

The pen should be discarded after this period, even if medicine remains inside.

Always check the expiry date and follow the storage instructions provided in the Patient Information Leaflet.

Warnings

Mounjaro Warnings and Precautions

Mounjaro is a prescription-only medicine and is not suitable for everyone.

Before treatment begins, tell your prescriber about your complete medical history and all medicines you currently use.

Extra care may be required if you:

  • Have previously experienced pancreatitis
  • Have severe digestive problems, including severe gastroparesis
  • Have gallstones or gallbladder disease
  • Have kidney problems or are at increased risk of dehydration
  • Have diabetic retinopathy or significant diabetic eye disease
  • Use insulin or sulphonylurea medicines
  • Are due to undergo a procedure involving general anaesthesia or deep sedation
  • Have another significant medical condition

Mounjaro is not licensed for weight management in people under 18 years of age.

Mounjaro is not used as a treatment for type 1 diabetes.

Do not use Mounjaro if you are allergic to tirzepatide or any of the ingredients contained in the medicine.

Mounjaro and pregnancy

Mounjaro should not be used during pregnancy.

If you are planning to become pregnant, tirzepatide should normally be stopped at least one month before a planned pregnancy.

Speak to your healthcare professional immediately if you become pregnant while receiving treatment.

Mounjaro and contraception

Tirzepatide delays stomach emptying and may affect the absorption of some oral medicines.

For women with overweight or obesity who use an oral contraceptive pill, reduced contraceptive effectiveness cannot be completely excluded when Mounjaro treatment begins or the dose is increased.

Current UK prescribing guidance advises considering:

  • Switching temporarily to a non-oral contraceptive method; or
  • Adding a barrier method of contraception

This additional precaution should generally be used for four weeks after starting Mounjaro and for four weeks following each dose increase.

Discuss contraception with your prescriber if this applies to you.

Mounjaro and breastfeeding

If you are breastfeeding or planning to breastfeed, discuss this with your prescribing healthcare professional.

Current UK prescribing information indicates that tirzepatide may be considered during breastfeeding in some circumstances, but the decision should be made individually following professional medical advice.

Mounjaro and surgery or sedation

Mounjaro can slow stomach emptying.

If you are due to have surgery or another procedure requiring general anaesthesia or deep sedation, make sure the medical team knows that you are taking tirzepatide.

Your healthcare professionals will advise you what to do before the procedure.

Directions

How to use a Mounjaro KwikPen

Mounjaro is available as a multi-dose KwikPen containing four weekly doses of the same strength.

Always follow the instructions supplied with your particular pen and the directions given by your prescriber.

Mounjaro is injected under the skin into one of the recommended areas:

  • Abdomen
  • Thigh
  • Back of the upper arm

If injecting into the back of the upper arm, another person should normally administer the injection.

Rotate your injection site each week rather than repeatedly injecting into exactly the same area.

Mounjaro should not be injected into a vein or muscle.

Before injecting Mounjaro

Before each injection:

  • Wash your hands.
  • Check that the pen contains Mounjaro.
  • Confirm that the strength matches your prescribed dose.
  • Check the expiry date.
  • Inspect the pen for damage.
  • Look at the medicine through the pen window.
  • Make sure the solution is clear and colourless to slightly yellow.
  • Do not use the medicine if you notice particles or significant discolouration.
  • Attach a new compatible needle for every injection.

Needles are not supplied as part of the Mounjaro KwikPen pack.

Never share your Mounjaro pen with another person.

Dispose of used needles immediately in a suitable sharps container.

Ingredients

What ingredients are in Mounjaro?

The active ingredient in Mounjaro is tirzepatide.

Tirzepatide is a dual GIP and GLP-1 receptor agonist used for appropriate patients requiring treatment for weight management or type 2 diabetes.

The Mounjaro KwikPen also contains:

  • Sodium phosphate dibasic heptahydrate
  • Sodium chloride
  • Glycerol
  • Phenol
  • Benzyl alcohol
  • Hydrochloric acid and sodium hydroxide for pH adjustment
  • Water for injections

The Mounjaro KwikPen therefore does contain ingredients used as preservatives, including phenol and benzyl alcohol.

If you have any known allergies or sensitivities, discuss them with your prescriber before starting treatment.

Important Information

Mounjaro contains tirzepatide and is a prescription-only medicine.

Treatment must only be used after an appropriate clinical assessment and exactly as directed by your prescriber.

Completing a consultation with Chesterfield Delivery Pharmacy does not guarantee that Mounjaro will be prescribed. Treatment will only be supplied where a qualified healthcare professional considers it appropriate.

Always read the Patient Information Leaflet supplied with your medication before using Mounjaro.

The information provided on this page is intended for general educational purposes and does not replace personalised advice from your doctor, pharmacist or prescribing healthcare professional.

Reviews

There are no reviews yet.

Be the first to review “Mounjaro Weight Loss Injection”

Your email address will not be published. Required fields are marked *

Treatment Options

  • Easy-to-use auto injector ✔
  • Minimal side effects ✔
  • Long-term results ✔
  • Complementary to lifestyle changes ✔
  • Age range: 18–75
  • Price from: £99.99
  • Easy-to-use auto injector ✔
  • Minimal side effects ✔
  • Long-term results ✔
  • Complementary to lifestyle changes ✔
  • Age range: 18–75
  • Price from: £149.99
  • Easy-to-use auto injector ✔
  • Minimal side effects ✔
  • Long-term results ✔
  • Complementary to lifestyle changes ✔
  • Age range: 18–75
  • Price from: £39.99

Verified customer reviews